hg_236079.1

Basic information about the TSS

---

TSS ID: hg_236079.1 Species: human Chr: chr1		Start: 63593747 End: 63593748 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000540265.5 NM_001172819 AK293298 Distance: 61 GeneID: 5236 HGNC/MGI_ID: HGNC:8905 UniProt_ID: B4DDQ8 P36871

Gene_name: phosphoglucomutase 1 Gene_symbol: PGM1 Gene_synonyms: Gene_source: HGNC:8905

TATA-Box annotation

---

Distance to TSS:	5627
Nearest PromoterID:	NM_177528
Entrez ID:	6799
Nearest Unigene:	Hs.546304
Nearest Refseq:	NM_001054
Nearest Ensembl:	ENSG00000197165
Gene Name:	phosphoglucomutase 1
Gene Alias:	HAST4|P-PST|P-PST 2|ST1A2|STP2|TSPST2
Gene Description:	sulfotransferase family 1A member 2
Gene Type:	protein-coding
CpG%:	0.055
GC%:	0.656716
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PGM1 p2@PGM1 p3@PGM1 p4@PGM1 p5@PGM1 p6@PGM1
Sample		p1@PGM1	p2@PGM1	p3@PGM1	p4@PGM1	p5@PGM1	p6@PGM1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.47	1.17	0.19	1.95	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	41.68	0.81	0.40	1.42	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	34.14	1.54	0.19	1.35	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.32	0.83	0.42	0.62	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.92	1.12	0.22	1.57	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	35.08	0.97	0.58	1.74	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	33.34	2.18	0.65	0.87	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	33.18	0.73	0.24	1.21	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.20	0.43	0.64	1.71	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.72	0.58	0.58	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	26.68	0.81	0.00	0.81	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.80	1.63	0.00	1.63	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	32.24	4.51	0.64	0.32	1.93	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	28.27	3.91	0.75	0.60	1.65	1.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.47	3.29	1.10	0.00	1.10	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.19	5.78	1.01	0.25	1.01	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	34.73	3.06	1.31	0.22	1.53	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.12	3.80	1.69	1.27	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.39	3.20	0.53	0.00	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.27	4.36	0.60	0.15	2.71	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.60	4.41	0.67	0.40	1.34	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.96	4.83	0.52	0.86	1.55	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	31.67	3.23	1.03	0.39	0.90	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	26.21	3.88	0.49	1.21	1.21	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.15	3.10	0.52	0.52	0.26	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.69	3.48	0.32	0.95	2.85	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	30.77	2.20	0.00	1.10	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	31.36	3.30	1.18	1.41	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.17	4.04	0.48	0.00	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.61	3.98	0.54	0.36	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.01	2.51	0.84	0.21	1.05	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.20	2.54	0.98	0.59	1.76	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	37.14	4.01	0.42	0.42	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.01	2.14	1.81	0.49	1.81	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	25.62	2.62	1.31	1.50	1.68	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.85	4.22	0.57	0.19	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.87	4.50	1.02	0.41	1.02	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	23.17	2.22	0.81	0.60	1.21	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.96	4.59	0.54	0.81	1.62	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.20	2.64	0.72	0.00	0.48	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	17.64	3.53	0.71	0.47	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	31.18	3.37	0.44	0.59	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.24	2.95	0.84	0.63	1.48	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.52	4.37	0.87	0.17	2.27	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.07	5.22	0.20	0.00	1.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.10	2.09	0.47	0.47	1.63	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.35	3.12	0.96	0.00	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.67	4.17	0.30	0.30	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.71	2.87	0.72	0.96	1.91	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.42	1.62	1.21	0.40	1.82	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.92	2.46	1.02	0.61	2.46	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.02	4.23	0.22	0.44	1.56	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	4.61	1.06	1.42	0.00	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.23	1.33	0.66	0.66	0.99	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	23.49	1.68	4.19	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	1.38	1.38	1.38	0.46	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.42	4.86	0.97	0.00	2.59	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.74	5.14	1.61	0.00	1.28	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	12.89	1.89	1.26	1.26	2.51	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	2.82	0.71	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.07	3.36	0.56	0.56	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	28.66	2.39	1.59	1.59	3.98	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.37	1.36	2.04	0.68	3.40	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.69	5.52	0.65	1.95	1.62	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.97	3.55	1.06	0.71	1.77	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.15	1.95	0.49	1.46	0.98	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.72	1.49	1.49	1.98	0.99	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.62	4.22	0.00	0.47	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.12	2.32	1.32	0.66	2.65	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.18	4.33	1.55	0.93	2.78	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	36.69	4.28	0.61	0.92	1.22	1.83
Adipocyte - breast, donor1	11376-118A8	117.20	5.86	3.64	6.81	1.43	1.27
Adipocyte - breast, donor2	11327-117E4	158.82	8.50	2.41	4.01	3.37	1.12
Adipocyte - omental, donor1	11473-119C6	205.85	9.03	5.22	10.69	2.42	2.29
Adipocyte - omental, donor2	11474-119C7	152.49	12.71	4.48	6.73	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	116.55	8.04	2.68	6.36	1.67	2.01
Adipocyte - perirenal, donor1	11476-119C9	223.93	13.40	4.47	8.29	3.19	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	115.45	6.60	4.40	5.50	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	68.20	7.23	1.81	3.16	3.61	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	104.27	13.55	3.48	3.65	5.39	2.09
Adipocyte differentiation, day04, donor1	13019-139D4	47.13	6.06	1.96	1.56	5.67	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	44.53	3.35	0.51	0.77	1.80	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	36.24	3.90	2.79	0.56	3.90	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	54.08	4.70	1.18	0.59	5.29	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	332.19	16.41	2.73	12.87	3.86	2.65
Adipocyte differentiation, day08, donor2	13023-139D8	66.81	7.75	0.65	2.90	4.84	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	105.04	5.33	1.60	1.60	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	175.83	13.91	2.23	3.90	4.45	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	312.75	14.14	2.91	12.89	2.50	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	113.53	8.79	1.26	6.28	3.52	3.01
Adipocyte differentiation, day12, donor3	13027-139E3	175.40	12.11	1.96	6.87	4.58	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	179.33	9.74	2.44	6.09	3.65	3.65
Alveolar Epithelial Cells, donor1	11510-119G7	67.63	5.30	0.66	1.33	1.33	2.21
Alveolar Epithelial Cells, donor2	11590-120G6	30.12	7.17	0.36	0.36	2.15	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	27.55	10.78	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	92.11	5.04	2.34	1.98	0.90	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	78.65	3.35	3.35	1.67	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	71.91	7.40	1.85	3.08	1.64	1.64
Anulus Pulposus Cell, donor1	11248-116E6	47.26	4.81	5.03	1.26	1.14	0.23
Anulus Pulposus Cell, donor2	11463-119B5	42.86	4.41	2.45	0.49	3.43	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	0.90	1.35	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.93	0.43	1.30	0.43	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.05	1.20	0.60	0.00	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	1.26	1.26	0.00	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	0.66	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.57	0.97	0.97	1.30	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.65	0.00	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	1.19	0.59	0.00	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	0.38	2.64	0.75	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.16	1.45	2.18	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	0.00	0.00	2.51	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.25	1.48	1.32	0.49	0.82	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	2.73	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.08	0.75	0.75	0.30	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	2.68	0.54	0.00	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.55	0.76	0.94	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.18	0.53	1.07	0.53	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	0.00	2.93	0.98	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.09	1.33	1.33	0.17	0.17	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	0.00	0.00	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.12	0.86	2.06	0.51	1.03	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	0.49	2.91	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.39	0.76	1.14	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.25	0.57	1.71	1.14	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.96	0.64	0.64	0.21	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.84	1.03	1.29	0.52	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.08	1.88	0.94	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.79	0.96	0.64	0.96	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	2.14	2.14	0.71	2.14	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	0.00	0.58	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.56	0.30	1.81	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	0.00	1.19	0.00	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	14.75	1.02	1.02	0.00	2.54	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.03	1.53	0.51	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	0.64	0.64	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.54	1.73	2.16	0.43	0.86	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.49	0.64	1.91	0.21	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.92	1.16	1.45	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	0.94	0.00	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.41	1.02	1.86	0.34	0.68	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	0.00	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.94	1.29	1.29	0.64	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.24	0.60	0.60	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	1.46	1.46	0.00	0.00	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.48	2.07	0.23	0.69	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	15.25	1.02	1.53	0.25	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.75	1.03	0.62	0.21	0.62	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.69	0.31	1.22	0.92	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.30	0.00	0.48	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	2.00	0.89	0.22	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	0.55	2.22	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.30	2.12	1.59	0.53	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.27	0.73	0.36	0.36	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	32.06	2.33	1.84	0.98	0.61	0.61
Astrocyte - cerebellum, donor2	11580-120F5	25.33	2.05	1.71	0.51	0.51	0.34
Astrocyte - cerebellum, donor3	11661-122F5	22.44	2.94	0.21	0.42	0.84	2.73
Astrocyte - cerebral cortex, donor1	11235-116D2	26.14	1.39	1.39	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	21.52	1.46	0.81	1.29	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	26.55	1.19	0.60	1.04	1.04	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	54.70	5.28	1.83	0.92	1.95	1.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	44.48	3.76	0.88	0.88	0.63	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	49.27	4.89	0.46	0.23	0.80	1.48
Basophils, donor1	12241-129G9	17.52	0.52	0.00	0.00	0.26	0.00
Basophils, donor2	12242-129H1	22.73	0.72	0.00	0.36	0.36	0.36
Basophils, donor3	12243-129H2	13.23	0.15	0.29	0.29	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	23.93	5.61	0.22	0.00	0.86	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	32.46	6.40	0.00	0.91	1.37	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	5.02	0.63	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	45.13	6.86	0.62	1.25	1.46	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	18.42	5.53	1.84	0.00	1.15	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	23.93	2.70	1.26	0.36	0.36	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	19.07	0.41	0.31	1.34	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	75.69	4.89	0.47	1.16	1.40	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	39.65	1.92	0.32	0.96	0.96	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.83	1.69	0.56	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	11.88	0.93	0.19	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	13.39	1.32	0.44	0.44	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.25	0.00	0.85	0.28	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	24.64	1.14	0.76	0.00	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	17.42	0.00	0.66	0.33	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	17.92	0.87	0.58	0.29	0.72	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	19.92	0.91	0.30	0.00	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	14.45	1.18	0.24	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	14.56	1.17	0.00	0.17	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.00	0.55	0.00	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.66	0.25	0.50	0.50	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.90	0.39	0.39	0.59	0.59	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.82	0.71	0.36	0.00	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.32	0.44	0.65	0.00	0.87	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.45	0.94	0.00	0.00	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.84	1.06	0.53	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.13	1.34	0.45	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.78	0.20	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.66	0.42	0.21	0.42	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.58	1.60	0.23	0.00	0.46	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.38	0.68	0.45	0.68	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.04	0.44	0.44	0.00	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.22	0.54	0.54	0.00	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.40	1.22	0.35	0.17	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.99	0.00	1.68	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.88	0.92	0.55	0.00	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.57	0.00	0.00	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.34	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	14.12	0.70	0.00	0.00	0.00	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	1.49	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.30	0.65	0.22	0.00	0.43	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	19.25	2.46	1.23	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.44	0.70	0.00	0.23	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.74	0.46	0.00	0.00	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	15.04	0.22	0.65	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	14.55	0.23	1.15	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	19.28	0.65	0.00	0.43	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	38.31	0.78	2.02	0.31	0.62	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	30.21	0.70	0.87	0.35	1.40	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	37.90	1.78	0.67	0.67	1.34	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	10.97	0.77	1.02	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	11.86	1.32	0.66	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	15.16	1.26	0.63	0.21	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	22.37	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	25.89	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	21.85	1.60	1.60	0.53	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	24.12	1.61	0.54	0.00	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	22.46	1.40	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	20.39	0.00	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	22.19	0.82	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.78	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	20.70	0.50	0.00	0.50	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3.64	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.20	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	22.09	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	13.48	1.12	0.56	0.00	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	40.96	4.88	0.75	0.38	0.75	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	41.71	3.83	1.58	0.68	1.80	1.35
CD4+ T Cells, donor1	11225-116C1	11.78	1.43	0.36	0.71	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	20.21	1.84	0.61	0.61	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	17.69	1.52	0.91	0.00	0.61	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	26.54	1.53	1.53	0.00	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	35.94	0.67	0.67	0.45	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.05	0.29	0.57	0.29	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	19.44	0.95	1.42	1.42	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.18	2.81	0.70	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	35.12	2.02	1.16	0.00	0.43	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	26.27	1.19	1.69	0.17	0.34	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.12	0.81	0.32	0.00	0.64	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.07	0.45	0.45	0.90	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	31.10	1.05	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	32.12	0.44	1.32	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	48.49	2.11	0.42	0.42	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.50	1.04	0.83	0.42	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	39.76	1.67	1.00	0.00	0.00	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.37	1.36	0.54	0.00	0.27	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	33.23	2.14	2.14	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	3.59	1.79	0.00	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	53.22	2.41	0.56	0.37	1.11	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	36.82	1.08	1.52	0.22	0.43	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	37.41	0.63	1.05	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	24.27	1.01	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.06	2.60	2.17	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	28.33	0.44	1.31	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	36.13	2.97	0.99	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	26.77	0.92	0.00	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	1.40	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	39.05	1.38	1.94	0.00	0.28	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	42.70	0.98	1.47	0.00	0.49	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	1.54	1.54	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.75	1.43	2.15	0.36	1.43	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	31.85	4.15	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	23.90	0.65	0.33	0.33	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	14.27	0.38	0.00	0.75	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	16.92	0.76	1.26	0.50	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	16.29	0.92	0.23	0.46	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.42	0.72	0.24	0.96	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	15.32	1.64	0.00	0.82	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.31	1.20	0.60	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.72	0.72	0.00	0.24	0.00	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.23	0.68	0.00	0.68	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	16.73	1.30	0.65	0.22	0.22	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.32	1.58	0.26	0.53	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.53	0.94	0.23	0.47	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.91	0.60	0.60	0.30	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.98	0.58	0.29	0.00	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.25	1.07	0.27	0.00	0.00	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.14	1.31	0.00	1.31	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.22	1.37	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	0.00	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.16	0.72	0.36	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.51	0.58	0.00	0.00	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.66	1.18	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.16	0.95	0.32	0.32	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	0.92	0.00	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.82	1.28	0.64	0.64	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.68	0.76	0.76	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.06	1.58	1.18	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	3.78	0.76	0.00	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	14.45	4.01	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	14.69	0.00	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	1.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	54.83	7.31	0.00	1.83	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	29.65	1.98	0.49	0.00	0.99	1.48
Cardiac Myocyte, donor3	11686-122I3	242.14	11.05	1.58	11.15	2.74	1.26
Chondrocyte - de diff, donor1	11261-116G1	53.73	4.16	2.43	2.08	3.12	2.43
Chondrocyte - de diff, donor2	11338-117F6	78.18	5.33	2.13	2.49	2.13	1.42
Chondrocyte - de diff, donor3	11410-118E6	68.15	5.58	4.32	3.64	2.28	0.91
Chondrocyte - re diff, donor2	11339-117F7	97.58	8.06	3.58	3.58	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	130.22	15.37	2.43	2.02	3.24	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	17.10	1.61	0.92	0.46	0.57	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	19.03	2.14	0.86	0.64	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	16.90	2.21	0.80	0.53	0.27	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	48.88	2.84	2.66	1.83	0.92	0.73
Corneal Epithelial Cells, donor1	11526-119I5	37.33	5.05	1.10	0.00	0.66	1.54
Corneal Epithelial Cells, donor2	11606-120I4	46.64	7.96	2.28	0.00	3.41	3.41
Corneal Epithelial Cells, donor3	11687-122I4	31.95	7.92	1.02	0.26	1.79	1.28
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.37	0.33	1.16	0.00	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	16.40	0.63	0.63	0.00	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.42	0.43	0.43	0.00	0.65	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	25.96	0.68	0.34	0.34	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.02	2.61	0.00	0.00	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.68	0.97	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	23.35	0.83	0.50	0.67	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	17.60	0.00	0.00	0.00	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	18.10	1.13	0.57	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	7.86	0.00	0.39	0.39	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	6.98	0.58	0.00	0.58	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	10.59	0.94	0.94	0.24	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	16.83	0.88	0.88	0.35	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.62	0.66	0.44	0.89	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.65	0.61	1.22	0.30	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.04	0.56	0.56	0.28	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.13	0.00	0.59	0.00	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	0.52	1.04	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	16.02	0.57	0.57	0.99	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	11.60	0.40	0.00	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	0.52	1.57	0.52	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.21	1.24	0.62	0.25	0.25	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.12	1.09	0.22	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.46	0.49	0.00	0.00	0.12	0.37
Endothelial Cells - Vein, donor1	11267-116G7	10.24	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.05	0.70	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.31	0.63	0.31	0.16	0.00	0.63
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	34.66	1.65	1.65	1.65	0.00	1.65
Eosinophils, donor3	12246-129H5	24.97	3.57	0.00	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	34.69	4.40	0.24	0.49	0.98	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	8.32	0.00	0.00	6.24	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	76.77	9.44	2.87	2.87	1.64	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.64	1.53	1.20	1.53	0.66	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	37.70	3.14	1.73	2.06	1.84	1.95
Fibroblast - Aortic Adventitial, donor1	11245-116E3	35.66	2.06	1.70	2.79	0.49	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	39.85	1.77	1.50	2.87	0.41	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	41.77	3.48	2.64	1.90	1.05	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.57	1.05	0.26	1.58	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	21.93	1.33	0.66	0.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	91.18	5.44	3.18	4.54	2.27	1.81
Fibroblast - Cardiac, donor2	11345-117G4	31.83	2.27	0.00	0.76	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	26.81	1.58	1.10	0.79	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	41.53	1.52	2.42	2.12	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	17.01	1.27	0.63	0.25	0.51	0.38
Fibroblast - Cardiac, donor6	11460-119B2	14.55	0.76	0.30	0.30	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	51.32	2.95	3.35	0.80	0.67	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	39.26	2.16	1.73	0.86	1.29	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	0.00	1.46	0.00	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	35.06	4.38	0.92	0.00	1.85	2.31
Fibroblast - Conjunctival, donor3	11692-122I9	37.48	3.05	3.90	0.51	1.19	0.68
Fibroblast - Dermal, donor1	11269-116G9	24.42	2.35	1.41	0.94	1.88	1.17
Fibroblast - Dermal, donor2	11346-117G5	33.02	3.30	0.94	0.00	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	14.99	1.81	2.42	0.36	1.45	1.57
Fibroblast - Dermal, donor4	11450-119A1	22.27	2.71	0.90	0.79	1.70	0.57
Fibroblast - Dermal, donor5	11454-119A5	27.04	2.09	0.52	0.87	0.87	1.92
Fibroblast - Dermal, donor6	11458-119A9	22.90	2.44	1.14	0.65	0.65	2.44
Fibroblast - Gingival, donor1	11237-116D4	42.48	3.12	2.29	0.21	0.42	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	60.26	2.10	2.62	1.83	1.31	0.79
Fibroblast - Gingival, donor2	11318-117D4	27.81	2.64	1.05	0.13	1.84	0.92
Fibroblast - Gingival, donor3	11394-118C8	33.07	2.42	4.35	0.39	1.26	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	34.28	3.12	2.08	0.00	2.08	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.78	3.35	0.70	1.41	1.41	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.89	1.87	1.40	0.47	1.56	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	34.75	2.98	1.76	0.27	1.76	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	25.41	2.82	2.47	0.35	1.06	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.00	3.07	1.90	0.73	1.32	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	31.36	3.41	1.23	0.55	1.77	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.54	1.65	0.22	0.44	1.21	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.79	2.35	2.35	1.03	2.93	1.47
Fibroblast - Lung, donor1	11270-116H1	32.62	4.08	2.72	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	2.98	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	21.10	1.27	0.42	0.63	1.48	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	58.31	6.66	2.50	0.00	3.33	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	69.93	8.39	0.00	4.20	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	27.99	2.24	1.12	1.12	1.12	1.40
Fibroblast - Mammary, donor1	11540-120B1	43.84	6.09	2.44	0.81	1.62	1.22
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99	0.00	3.99	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.31	1.94	0.78	0.58	0.78	1.75
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.09	4.40	0.46	0.61	1.67	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.15	1.22	1.53	1.22	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	28.62	4.20	1.14	0.00	3.05	3.05
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	30.51	1.35	1.35	0.54	1.62	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.31	4.52	2.09	0.35	2.20	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	36.25	1.22	1.88	1.88	0.11	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	26.41	1.63	0.81	0.81	1.02	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	5.35	1.34	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	1.19	2.37	0.00	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	39.49	1.98	1.39	0.79	1.19	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.23	3.37	4.44	1.07	2.49	1.95
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	57.15	7.29	3.55	1.38	1.77	2.37
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	38.81	2.11	1.20	0.00	0.60	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	40.27	4.21	2.48	0.65	2.81	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	64.79	3.54	2.53	2.02	2.28	1.01
Fibroblast - skin normal, donor1	11553-120C5	46.93	4.27	2.95	0.82	1.48	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	48.92	1.20	2.01	1.60	1.60	1.40
Fibroblast - skin normal, donor2	11561-120D4	54.95	5.83	2.71	1.71	1.71	2.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	79.19	1.81	1.81	2.72	0.60	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	46.64	6.30	1.99	1.82	2.24	1.57
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	52.31	4.62	5.13	1.20	3.25	2.39
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	51.24	2.63	0.33	0.66	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	39.95	3.94	2.24	0.75	1.92	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	49.59	2.87	1.35	1.01	2.02	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.21	3.92	3.45	1.25	1.88	1.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	1.74	3.49	0.00	2.61	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.22	2.43	0.69	1.91	1.04	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.17	2.34	1.82	0.78	1.04	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.34	1.79	0.51	1.53	1.02	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	68.90	6.12	0.77	3.83	1.53	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	68.27	5.10	1.28	3.83	2.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	63.61	9.98	0.57	5.13	2.85	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.17	3.31	0.28	0.28	1.10	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.46	2.74	0.91	1.83	0.68	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	49.93	8.92	1.59	2.97	3.76	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	10.04	3.44	0.26	0.53	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	14.68	2.28	0.33	0.65	1.30	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	36.26	7.96	0.00	0.88	3.98	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	158.56	14.98	2.40	7.77	2.40	2.26
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	104.18	9.73	0.99	4.31	1.60	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	102.35	11.82	0.81	5.64	1.34	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	76.81	8.05	0.37	2.48	1.49	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	105.76	12.46	0.69	3.46	1.52	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	99.01	9.35	0.61	3.25	1.42	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	90.59	4.11	1.60	4.11	1.37	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	96.79	6.35	0.87	3.86	1.49	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	158.25	15.74	0.87	5.25	0.66	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	72.69	4.43	1.77	2.95	1.48	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	104.28	8.58	1.11	6.20	0.32	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	189.68	13.18	1.56	11.17	1.12	2.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	66.34	5.04	0.81	1.81	1.81	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	61.07	5.77	1.02	3.22	0.85	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	138.42	7.63	1.15	7.18	1.06	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	68.68	5.83	1.46	1.66	1.56	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.53	5.46	0.68	1.88	1.20	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	60.31	5.86	1.55	2.88	1.66	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	104.58	7.90	1.75	3.24	1.50	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	113.93	6.33	1.63	3.88	1.43	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	46.42	4.95	0.62	0.83	2.48	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	55.34	7.38	0.58	1.15	2.42	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	48.03	4.50	1.17	2.00	1.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.80	4.19	0.44	0.44	2.42	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.62	4.80	1.23	2.21	1.11	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.98	4.05	1.78	1.62	1.30	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.69	4.17	1.28	0.64	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	51.26	5.21	0.57	1.23	2.27	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	45.24	3.32	1.42	0.63	0.79	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.10	1.82	0.91	0.61	1.82	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	43.38	3.87	1.36	1.25	1.25	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.06	5.49	0.44	1.10	1.32	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.91	1.68	0.56	1.12	1.68	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.33	1.20	0.56	0.37	0.28	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	37.70	2.14	1.60	0.80	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.72	0.92	1.22	1.07	0.92	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.86	0.52	0.26	0.52	0.13	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.38	2.44	1.63	0.54	1.08	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.97	1.29	0.74	1.11	1.84	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.27	1.10	1.32	0.88	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	4.96	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.93	1.32	1.85	1.19	0.79	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.44	1.21	1.01	0.40	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	46.26	5.34	2.80	2.29	1.27	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	98.73	10.15	0.80	4.18	1.39	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	109.24	11.25	0.92	4.62	1.69	2.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	86.54	10.84	1.43	4.30	2.66	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	51.32	3.13	0.63	2.19	2.50	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	60.75	6.22	0.57	1.98	0.85	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	53.50	6.92	0.00	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	56.92	9.90	0.00	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	79.30	5.03	0.77	3.48	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	77.01	4.81	1.60	4.81	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	83.46	3.48	1.74	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	87.88	5.21	0.98	2.28	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	84.83	5.35	1.24	3.29	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	3.33	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	81.10	6.99	1.40	3.92	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	84.65	5.23	1.63	5.56	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	69.62	5.87	1.68	1.68	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	93.51	10.18	0.95	2.54	0.95	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	88.31	6.45	0.68	3.40	0.68	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	73.09	6.26	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	91.63	6.87	1.15	0.57	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	72.22	6.81	0.59	2.07	1.78	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	45.74	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	57.99	4.14	1.24	2.07	1.24	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	64.90	5.29	0.23	3.22	2.07	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	10.54	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	52.28	5.77	0.38	1.54	1.15	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.24	5.54	0.33	1.30	1.63	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	37.46	9.36	2.01	1.34	2.01	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	62.80	10.02	1.16	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	48.27	8.22	1.37	1.03	2.40	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	4.97	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	45.30	12.27	0.94	2.36	1.42	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	49.49	10.26	2.41	0.00	3.02	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.57	8.65	1.02	1.53	2.03	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	38.69	7.98	1.20	2.39	0.80	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.44	7.40	0.49	0.99	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	34.23	2.36	0.00	1.18	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	35.01	6.42	0.00	0.58	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.89	14.92	3.07	0.88	1.32	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	4.24	0.00	0.85	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	63.27	2.39	1.19	2.98	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	63.08	9.70	1.94	0.49	2.91	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	43.37	0.00	4.57	0.00	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.79	1.25	0.00	0.42	1.66	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	32.61	4.50	0.00	0.00	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.79	2.22	4.76	1.90	1.27	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	34.67	4.18	5.01	0.84	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	50.59	3.95	1.16	1.16	1.62	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	62.12	5.06	1.18	1.52	1.69	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	56.88	3.64	1.37	0.91	0.91	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	54.87	3.17	1.20	1.09	0.77	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	59.96	5.80	1.50	0.86	1.72	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	58.34	5.60	1.29	1.29	1.94	2.15
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	52.80	4.11	1.99	1.87	1.37	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	52.84	5.15	1.54	0.86	2.06	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	57.67	4.81	0.64	1.60	0.32	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	18.47	1.68	0.00	0.00	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.46	2.16	0.00	0.43	0.00	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	90.65	7.05	3.17	4.23	1.41	3.53
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	85.00	7.27	0.73	2.91	2.18	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	26.93	2.10	1.22	0.87	0.70	0.00
Hepatocyte, donor1	11523-119I2	308.70	8.47	3.63	9.68	3.63	1.21
Hepatocyte, donor2	11603-120I1	200.38	15.08	1.08	3.23	1.08	3.23
Hepatocyte, donor3	11684-122I1	163.20	15.95	1.84	4.29	3.07	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	29.37	0.65	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	15.91	2.80	0.35	0.70	0.70	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	47.34	2.47	1.23	1.78	0.55	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	44.72	3.59	1.55	1.06	0.90	1.63
Keratinocyte - epidermal, donor2	11349-117G8	35.14	2.93	0.59	0.59	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	25.65	5.21	0.66	0.66	1.42	1.70
Keratinocyte - oral, donor1	11251-116E9	45.52	8.06	3.63	0.68	1.48	1.14
Keratocytes, donor1	11527-119I6	30.94	2.06	0.69	0.69	1.72	0.34
Keratocytes, donor2	11607-120I5	35.15	2.34	1.17	0.00	0.00	2.34
Keratocytes, donor3	11688-122I5	26.48	2.96	0.40	0.40	1.38	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	0.00	3.24	1.08	0.00	4.31
Lens Epithelial Cells, donor2	11609-120I7	27.91	3.23	0.81	0.92	0.58	0.92
Lens Epithelial Cells, donor3	11690-122I7	46.52	2.12	1.92	2.72	0.50	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.21	0.83	0.24	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.05	0.28	1.12	0.28	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.45	0.79	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	1.08	0.54	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.92	0.00	0.63	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.44	0.54	0.22	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.10	0.51	0.51	0.00	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.46	0.14	0.42	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4.35	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.60	0.78	0.39	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.59	0.56	0.00	0.37	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.76	1.05	0.35	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.69	0.24	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.46	0.14	0.55	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.62	0.92	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	0.00	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.42	0.37	0.18	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.58	0.66	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.47	0.00	0.88	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.22	1.00	0.25	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	0.00	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.62	0.81	0.00	0.27	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.11	0.45	0.15	0.15	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	0.00	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.94	0.63	0.84	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.47	0.45	0.45	0.30	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.09	0.38	0.56	0.38	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.16	0.42	0.21	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	0.66	0.33	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.43	0.37	0.12	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.18	0.37	0.74	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	0.49	0.74	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.46	0.27	0.27	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.43	0.64	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.87	0.00	0.30	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.10	0.56	0.42	0.14	0.14	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	0.00	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.57	0.00	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.09	0.00	0.00	0.00	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	0.72	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.49	0.65	0.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	0.94	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.02	0.74	0.12	0.00	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.92	0.00	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.06	0.00	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4.60	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	1.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	0.70	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.12	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	3.39	0.00	0.00	0.45	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	4.36	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4.05	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	4.06	0.54	0.41	0.00	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	3.59	0.51	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	3.53	0.71	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1.33	1.33	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	2.04	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	3.20	0.00	0.27	0.00	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3.59	0.38	0.19	0.00	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.14	1.23	0.61	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.89	1.63	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	4.58	1.04	0.42	0.00	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	4.76	0.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6.18	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	2.61	0.58	0.00	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.78	0.30	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	3.32	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	5.30	0.35	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	6.27	0.74	0.00	0.00	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	3.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1.92	1.15	0.38	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	4.53	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.33	0.90	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	2.15	0.00	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.80	1.11	0.74	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.31	0.43	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	2.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6.00	1.33	0.00	0.33	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.22	0.00	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	0.71	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3.78	0.69	0.00	0.34	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	6.30	0.74	0.37	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	1.16	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	0.00	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	4.40	0.40	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.18	0.73	0.73	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1.53	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.45	1.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	1.88	0.94	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	5.03	1.01	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1.35	0.00	0.90	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	3.12	0.89	0.00	0.00	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	5.87	0.39	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	1.32	0.00	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.11	0.52	0.00	0.00	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.81	0.44	0.44	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	2.65	0.44	0.44	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	4.24	0.77	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	0.00	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.92	0.48	0.00	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	2.39	0.80	0.80	0.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1.82	0.61	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1.38	1.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	4.18	2.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	4.65	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.23	1.81	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	4.12	0.95	0.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	3.73	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1.72	1.72	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	4.11	2.06	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3.54	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	6.66	0.00	1.66	0.00	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	0.42	0.00	0.00	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.04	0.46	0.46	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	0.00	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.02	1.07	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.51	0.00	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	1.78	0.89	0.00	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	1.71	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	15.34	0.77	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.11	2.74	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.79	0.89	0.00	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.52	2.08	0.52	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.27	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	2.08	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	11.85	0.68	0.91	0.46	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	11.38	0.73	1.28	0.00	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	16.65	0.52	0.92	0.39	0.52	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	33.99	2.66	1.59	1.06	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	49.44	2.85	3.17	1.27	0.95	1.43
Mallassez-derived cells, donor3	11930-125I4	41.42	3.20	1.95	0.56	1.53	1.25
Mammary Epithelial Cell, donor1	11273-116H4	49.52	11.26	2.19	0.80	1.40	3.49
Mammary Epithelial Cell, donor2	11350-117G9	61.96	5.79	1.16	1.45	1.74	2.61
Mammary Epithelial Cell, donor3	11422-118F9	75.58	6.73	0.75	1.00	2.00	1.50
Mast cell - stimulated, donor1	11487-119E2	33.90	2.03	1.36	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	37.63	0.87	2.60	1.08	1.30	0.65
Mast cell, donor2	11565-120D8	22.59	1.19	0.30	1.49	1.19	0.89
Mast cell, donor3	11566-120D9	29.27	1.35	1.35	0.45	0.23	0.45
Mast cell, donor4	11567-120E1	25.88	2.30	2.30	1.24	0.53	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	35.04	1.11	1.89	0.44	1.00	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	34.44	1.17	0.58	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	42.10	1.38	2.18	0.92	0.80	0.23
Mast cell, expanded, donor8	11941-126A6	29.12	0.84	1.51	1.00	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	38.80	2.09	1.89	0.90	0.40	0.20
Melanocyte - dark, donor2	11582-120F7	26.99	1.73	1.73	0.00	0.69	2.08
Melanocyte - dark, donor3	11663-122F7	37.60	0.65	1.88	0.94	0.58	0.94
Melanocyte - light, donor1	11274-116H5	28.44	2.35	1.41	0.24	0.47	0.24
Melanocyte - light, donor2	11351-117H1	41.63	2.05	1.36	0.68	0.68	2.05
Melanocyte - light, donor3	11423-118G1	29.49	4.34	0.87	0.87	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	23.53	1.35	0.52	0.52	1.35	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	28.78	2.42	1.61	1.34	1.61	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	26.52	1.87	0.80	1.07	1.07	1.87
Meningeal Cells, donor1	11493-119E8	32.88	1.61	1.74	0.12	0.62	1.49
Meningeal Cells, donor2	11573-120E7	40.93	2.64	3.08	0.44	0.44	1.32
Meningeal Cells, donor3	11654-122E7	30.16	0.65	0.90	0.33	0.57	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	29.66	2.57	1.71	0.57	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.68	2.72	2.21	1.11	0.91	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	3.94	2.63	2.63	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	0.00	0.00	2.62	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	0.72	0.72	0.00	1.44	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.61	0.21	1.06	0.00	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	0.50	1.01	0.00	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	41.09	2.86	1.54	0.88	1.54	1.32
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	22.65	3.65	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	26.60	2.86	0.82	0.00	1.02	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	62.05	6.65	2.91	1.39	3.05	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	55.02	4.09	1.12	1.12	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	142.89	7.24	3.82	5.26	1.71	2.37
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	54.30	2.37	2.37	1.19	1.48	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	7.01	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	67.24	7.04	3.20	1.92	1.92	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.28	3.19	1.06	2.48	2.13	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	144.48	8.13	3.44	8.13	0.94	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	30.48	2.90	0.73	0.00	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	36.59	2.92	2.92	2.65	2.12	2.39
Mesothelial Cells, donor2	12156-128G5	38.54	2.50	1.50	2.50	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	25.00	2.75	1.88	0.87	1.16	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.76	0.74	1.23	0.25	0.25	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.61	1.77	0.59	0.29	0.59	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.02	0.62	0.00	0.00	1.24	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.52	0.83	0.62	0.00	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.77	0.75	0.50	0.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.50	0.00	0.47	0.00	1.86	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.09	0.61	0.20	0.20	1.02	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.84	1.19	0.79	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	0.00	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.76	1.14	0.38	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.01	0.21	0.85	0.00	0.85	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	0.92	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.84	0.30	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.55	0.75	0.50	0.25	0.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.21	1.90	0.71	0.00	0.71	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	2.76	0.55	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.74	1.15	0.23	0.23	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.73	1.89	0.21	0.00	0.21	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.53	0.82	1.22	0.20	0.41	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.73	0.86	0.43	0.21	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.23	1.11	0.67	0.44	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.17	0.44	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	0.00	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.14	0.00	0.27	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.18	1.18	0.29	0.00	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	16.35	0.00	0.00	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	0.96	0.00	0.00	0.48	2.88
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	0.00	0.80	0.00	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	1.37	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	0.00	0.00	0.50	2.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	2.04	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	29.78	2.63	0.00	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.69	2.56	0.00	0.00	0.64	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	35.70	1.98	0.25	0.50	1.24	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	0.70	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	2.21	0.00	0.00	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	43.76	2.74	0.00	1.37	1.71	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.94	0.00	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	25.92	4.62	0.71	1.07	2.13	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.68	3.09	0.84	1.12	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.64	0.42	0.00	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	34.38	1.17	0.00	1.17	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.47	3.32	0.00	0.90	0.60	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.61	0.83	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	14.44	0.00	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	31.40	0.92	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	8.54	1.14	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	32.75	2.21	0.14	0.55	0.83	1.38
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.32	2.33	0.00	1.04	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.72	1.72	0.00	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.23	0.64	0.00	0.00	3.81	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.55	1.87	0.00	0.27	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.28	1.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.43	1.70	0.00	0.57	0.99	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.71	2.55	0.00	0.00	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.94	0.88	0.00	0.00	0.66	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	26.54	3.03	0.00	1.14	1.52	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.16	1.42	0.00	0.85	0.28	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.03	0.49	0.00	0.00	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.29	1.96	0.00	0.00	3.26	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	1.18	0.00	0.29	0.59	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.09	1.15	0.58	0.00	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.73	1.24	0.41	0.82	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	0.00	1.19	0.00	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	1.78	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.71	0.99	0.33	0.33	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	1.05	0.00	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.42	0.40	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.02	1.50	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.58	0.80	0.27	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.79	0.45	0.23	0.11	0.57	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	22.35	0.73	0.00	0.37	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	1.56	1.56	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	0.00	1.01	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	0.42	1.26	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	43.95	2.59	1.51	0.86	1.94	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	35.02	1.57	3.66	3.66	1.57	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	2.67	2.00	0.00	1.33	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	2.09	1.25	0.00	1.25	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	14.07	4.75	0.95	0.57	1.14	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	0.00	1.60	0.00	4.79	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	2.72	1.36	0.00	0.68	4.76
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	0.00	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.30	2.09	1.67	0.42	3.35	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.64	3.72	0.70	0.23	1.86	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	2.97	0.27	1.08	1.62	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	27.96	1.05	0.84	1.26	1.68	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.77	2.98	2.48	0.50	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.51	3.52	1.62	0.27	2.71	2.71
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.01	3.17	1.13	1.13	1.13	2.95
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.19	4.57	0.65	0.33	1.96	2.94
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.70	2.00	1.28	0.55	2.55	2.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.10	4.77	2.65	0.53	2.12	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	3.60	1.20	1.80	4.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.08	4.92	2.63	0.98	6.24	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.22	3.74	0.81	0.65	3.09	2.28
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.22	5.29	0.35	0.71	2.82	1.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	2.11	2.11	1.41	1.41	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.31	5.06	0.46	0.92	5.52	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.78	4.82	1.29	1.61	1.29	2.57
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.31	5.86	3.10	0.69	1.72	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	5.06	5.06	0.00	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.72	2.67	1.56	1.56	1.78	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	3.81	0.85	0.00	2.12	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.28	3.09	2.61	0.71	1.90	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.75	6.87	1.72	0.43	3.86	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.99	2.33	0.33	0.33	3.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.99	3.16	0.45	1.35	3.16	3.61
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	1.98	1.59	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.93	4.64	2.79	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	21.57	3.03	2.27	1.14	3.03	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.01	5.54	0.65	0.33	1.30	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.07	1.74	1.74	0.44	1.31	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	2.26	1.36	0.45	1.81	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	4.41	0.88	0.00	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	8.64	1.33	0.00	3.32	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.79	3.97	1.49	0.99	1.98	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	6.51	1.15	1.15	2.68	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.24	4.23	3.02	1.51	2.72	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.87	3.76	0.66	0.44	1.77	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	3.39	2.03	2.03	4.07	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	0.00	0.00	5.11	5.11	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	4.27	1.22	1.22	2.44	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.22	2.20	1.26	0.94	2.83	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.11	4.84	0.91	0.91	1.82	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	24.53	2.37	2.37	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	5.67	1.13	2.27	4.53	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	0.00	10.12	5.06	0.00	5.06
Myoblast, donor1	11241-116D8	36.65	1.86	2.48	1.86	1.61	0.50
Myoblast, donor2	11322-117D8	37.97	4.60	0.96	1.15	1.92	0.96
Myoblast, donor3	11398-118D3	50.28	3.03	1.35	2.19	1.68	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.52	2.48	0.88	0.29	0.44	1.17
Natural Killer Cells, donor1	11230-116C6	33.52	0.92	0.92	0.62	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	19.00	0.60	1.51	0.90	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	25.22	0.92	0.37	0.18	0.18	0.55
Neural stem cells, donor1	11275-116H6	44.28	1.45	0.73	2.90	0.00	1.45
Neural stem cells, donor2	11352-117H2	36.59	3.85	1.93	3.85	1.93	1.93
Neurons, donor1	11494-119E9	12.52	0.00	1.14	1.14	0.00	1.14
Neurons, donor2	11574-120E8	15.85	1.54	0.44	0.66	0.44	0.00
Neurons, donor3	11655-122E8	9.87	0.82	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	22.27	1.86	1.86	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	34.79	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	47.03	3.05	1.22	3.05	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	62.81	6.17	4.63	1.42	2.37	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	38.75	2.28	1.63	0.98	0.98	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	32.49	4.81	1.80	0.20	1.60	1.40
Olfactory epithelial cells, donor1	11933-125I7	34.69	3.99	1.65	0.83	1.93	2.06
Olfactory epithelial cells, donor2	11934-125I8	35.75	3.62	2.17	0.43	1.88	2.32
Olfactory epithelial cells, donor3	11935-125I9	39.16	2.27	2.72	2.84	1.25	1.14
Olfactory epithelial cells, donor4	11936-126A1	52.30	4.87	2.53	1.95	3.99	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	54.16	5.42	1.20	0.60	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	79.12	7.66	4.47	5.10	4.04	1.28
Osteoblast - differentiated, donor2	11353-117H3	25.15	4.57	3.43	0.00	1.14	4.57
Osteoblast - differentiated, donor3	11425-118G3	29.17	3.10	0.62	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	54.92	3.71	2.35	1.56	1.37	1.76
Osteoblast, donor2	11354-117H4	63.91	5.62	2.11	0.70	1.40	2.81
Osteoblast, donor3	11426-118G4	95.62	9.24	1.42	2.67	3.73	2.31
Pancreatic stromal cells, donor1	11249-116E7	28.72	1.68	2.27	0.76	1.26	1.01
Pericytes, donor1	11491-119E6	31.49	1.45	2.34	0.89	0.45	0.33
Pericytes, donor2	11571-120E5	27.84	1.81	0.45	0.91	1.13	0.00
Pericytes, donor3	11652-122E5	101.52	11.60	1.02	4.07	2.85	2.03
Perineurial Cells, donor1	11499-119F5	44.19	4.18	1.24	2.03	1.13	1.24
Perineurial Cells, donor2	11579-120F4	29.63	1.01	1.84	0.64	0.46	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	20.08	1.91	0.96	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.20	0.73	0.73	0.24	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	20.71	0.52	0.26	0.52	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	51.18	2.63	1.20	1.67	0.96	1.67
Placental Epithelial Cells, donor2	11355-117H5	74.30	1.11	3.33	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	62.04	2.75	2.36	1.18	0.20	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	56.64	6.33	3.80	2.22	0.95	0.95
Preadipocyte - breast, donor1	11467-119B9	117.99	5.25	5.44	6.94	0.94	2.63
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	157.81	3.79	3.13	8.48	1.57	0.52
Preadipocyte - breast, donor2	11328-117E5	103.57	8.33	2.48	6.75	2.03	1.35
Preadipocyte - omental, donor1	11468-119C1	170.49	9.38	3.84	10.87	2.98	2.77
Preadipocyte - omental, donor2	11329-117E6	127.01	10.04	7.86	6.98	3.06	0.00
Preadipocyte - omental, donor3	11403-118D8	99.13	6.59	3.44	7.31	1.15	1.43
Preadipocyte - perirenal, donor1	11469-119C2	282.48	16.73	0.98	6.89	0.98	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	41.15	1.84	2.76	0.92	0.31	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	34.71	1.06	1.77	1.24	0.71	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	42.74	4.09	1.36	1.70	2.04	1.70
Preadipocyte - visceral, donor1	11280-116I2	39.12	2.24	1.86	1.12	2.24	1.30
Preadipocyte - visceral, donor2	11357-117H7	37.73	0.46	0.46	0.92	1.38	1.84
Preadipocyte - visceral, donor3	11429-118G7	27.59	1.88	0.94	0.42	0.73	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.30	0.60	0.00	0.15	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	55.65	4.74	1.08	3.79	1.08	1.62
Prostate Epithelial Cells, donor3	11404-118D9	12.98	4.29	0.43	0.12	0.92	1.65
Prostate Stromal Cells, donor1	11254-116F3	50.46	3.19	2.05	3.42	0.80	1.37
Prostate Stromal Cells, donor2	11332-117E9	28.69	4.12	1.61	0.54	1.43	0.72
Prostate Stromal Cells, donor3	11405-118E1	32.01	2.71	1.36	1.25	1.25	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	34.67	4.38	2.55	0.00	0.36	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.14	2.63	0.55	0.69	0.62	1.04
Renal Epithelial Cells, donor1	11517-119H5	20.80	1.01	0.51	1.01	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	34.14	2.13	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	38.85	3.81	1.27	0.53	1.16	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.69	0.40	0.40	0.13	0.54	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	18.87	2.22	0.44	0.89	0.44	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	0.00	0.00	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	38.30	2.86	1.10	1.54	0.88	0.44
Renal Mesangial Cells, donor2	11598-120H5	36.37	3.13	0.00	1.25	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	22.47	4.99	0.83	0.28	1.11	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	47.51	3.49	0.81	0.27	0.54	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.30	2.11	0.84	0.00	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	25.65	3.09	0.96	0.77	0.58	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.85	2.33	0.78	0.00	0.78	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.99	3.13	1.42	1.42	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	2.06	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.33	1.76	1.00	0.25	0.75	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	177.87	10.42	3.61	6.68	3.74	2.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	40.20	3.57	0.00	0.89	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.71	0.00	1.10	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	2.90	1.16	0.00	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.83	3.12	0.39	0.26	1.82	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.61	2.38	0.10	0.79	1.09	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	36.14	3.35	0.67	1.34	0.89	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.06	3.47	0.99	0.87	1.74	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	30.30	3.15	0.35	0.58	1.05	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	37.44	1.85	1.16	0.69	2.08	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.79	2.46	0.41	0.27	1.78	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.50	2.42	0.30	0.30	2.27	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	31.54	2.69	0.72	0.36	0.90	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	33.28	4.02	0.72	0.43	0.86	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.18	3.76	0.54	0.75	1.18	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.21	4.43	0.00	0.89	1.33	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.06	2.10	0.19	0.19	1.91	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.64	3.35	0.28	0.37	1.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.22	2.82	0.94	0.38	0.94	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.02	3.85	0.80	0.40	2.12	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.13	4.19	0.29	0.88	0.58	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.45	2.86	1.15	0.38	2.29	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.93	3.63	0.53	0.64	1.28	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	25.23	3.08	0.56	0.00	1.12	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.24	1.54	0.68	0.85	1.54	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.07	2.73	0.73	0.36	1.09	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.71	3.19	0.61	0.61	1.72	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.83	3.63	0.54	0.54	1.61	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.51	2.83	0.94	0.71	2.59	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.40	2.58	0.20	0.79	1.39	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.93	3.27	0.23	0.47	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	28.41	2.49	0.21	0.21	1.45	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	34.51	2.88	0.66	0.66	1.55	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.52	2.92	0.42	0.63	0.84	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	32.84	3.23	0.27	0.54	1.48	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	23.67	2.90	0.17	0.51	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.04	2.89	0.77	0.58	0.96	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	30.95	1.72	0.86	0.34	0.69	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	24.55	2.47	0.27	1.10	2.06	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.49	1.97	0.99	0.99	1.48	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.83	3.07	0.85	0.00	1.70	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.96	3.40	0.44	0.30	1.04	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.66	2.13	0.80	0.53	2.13	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	17.28	1.24	0.41	0.55	0.55	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	25.72	1.90	0.48	0.48	0.95	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	39.10	4.84	0.20	0.40	1.41	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	30.79	6.31	0.09	0.19	1.88	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.60	1.75	0.00	0.35	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.95	2.12	0.30	0.30	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	55.56	6.73	0.37	0.73	3.79	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	31.00	2.47	0.58	0.29	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	27.38	4.87	0.00	0.61	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.02	7.23	0.00	0.30	3.32	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	33.25	3.62	0.23	0.00	1.36	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	37.44	4.49	0.60	0.60	2.10	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.59	3.42	0.71	0.24	0.83	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	34.15	3.84	1.28	1.71	1.92	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	24.04	3.61	0.00	0.00	3.00	0.60
Schwann Cells, donor1	11498-119F4	19.00	1.50	0.38	0.19	0.19	0.94
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	27.82	0.88	1.53	0.66	0.66	0.44
Sebocyte, donor1	11220-116B5	42.73	4.93	1.10	3.29	2.19	0.55
Sebocyte, donor2	11301-117B5	31.71	4.60	0.46	0.46	2.30	3.68
Sebocyte, donor3	11378-118B1	26.18	2.27	1.44	0.41	1.65	1.03
Sertoli Cells, donor1	11255-116F4	193.82	18.22	1.66	8.28	0.00	4.97
Sertoli Cells, donor2	11333-117F1	265.49	11.30	2.82	14.12	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	25.60	3.17	1.94	1.14	1.50	2.02
Skeletal Muscle Cells, donor2	11358-117H8	31.81	1.45	2.17	1.45	2.17	1.45
Skeletal Muscle Cells, donor3	11430-118G8	66.05	4.18	0.00	0.00	3.34	4.18
Skeletal Muscle Cells, donor4	11451-119A2	43.20	4.08	2.20	0.47	1.10	2.04
Skeletal Muscle Cells, donor5	11455-119A6	43.70	4.01	1.78	1.64	2.38	1.93
Skeletal Muscle Cells, donor6	11459-119B1	29.40	1.85	1.23	0.77	2.31	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	51.79	4.91	6.68	1.64	0.63	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	46.80	6.56	3.42	0.71	1.00	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	37.01	3.47	1.09	1.88	0.79	1.98
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	35.30	3.71	2.27	1.94	1.26	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	2.90	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	47.33	2.34	2.34	1.24	0.55	1.10
Skin - palm, donor1	10286-104F7	24.17	8.06	0.00	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.42	3.46	0.14	0.86	1.30	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	97.33	0.82	0.82	0.82	0.82	4.91
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	31.94	2.73	0.65	0.78	0.91	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	41.01	5.56	1.53	2.50	0.83	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	19.13	2.67	0.70	1.27	1.41	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	62.59	4.86	0.63	1.48	1.27	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	18.29	7.27	0.67	0.45	2.10	2.70
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	55.55	5.25	0.31	0.93	4.94	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	38.24	3.11	0.22	0.67	2.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	4.70	1.76	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	38.45	3.76	0.88	1.55	0.66	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	35.83	0.79	1.18	1.58	1.97	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	36.31	2.32	0.00	2.32	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	2.00	5.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	56.56	3.59	4.13	3.19	1.06	2.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.56	1.77	3.55	1.11	1.33	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	65.17	6.40	1.79	1.66	1.79	1.79
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	29.95	0.65	1.30	2.60	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.76	1.48	2.07	2.07	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	70.61	7.97	1.57	3.56	1.57	3.27
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	41.97	5.37	1.46	0.81	1.79	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.31	5.18	0.91	0.91	3.65	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	49.50	2.02	3.28	1.01	1.26	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	40.53	3.81	1.43	1.91	2.38	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.34	3.83	2.36	1.62	1.77	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	52.30	3.23	2.80	2.37	2.80	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	38.20	4.72	1.05	1.57	1.15	1.78
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.17	1.86	1.55	1.24	1.24	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	31.26	1.08	0.00	0.00	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.48	3.29	1.49	0.30	0.90	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.09	4.78	1.37	1.02	0.68	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	48.77	6.20	3.46	1.02	1.57	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	44.38	4.53	2.31	2.92	1.91	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	38.68	1.37	1.14	0.91	1.37	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	51.32	6.64	1.21	0.60	2.42	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.16	2.38	1.06	0.00	0.53	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	17.58	2.00	0.53	0.67	1.33	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	42.57	4.13	3.13	1.38	1.75	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.13	1.52	2.79	1.52	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	24.88	1.06	1.51	1.06	0.90	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	3.00	0.75	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	29.72	27.14	0.00	0.00	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	55.34	5.12	1.40	1.86	0.93	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.91	1.51	2.02	0.50	2.02	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	46.70	3.45	2.51	2.19	1.88	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	38.05	4.72	0.88	0.59	1.47	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	24.74	2.58	1.33	0.58	0.67	1.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	3.27	1.87	0.93	0.00	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	52.53	3.60	2.30	0.86	1.01	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	40.54	3.57	1.27	1.02	1.02	3.57
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	48.70	3.57	1.13	1.69	0.75	2.26
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.22	3.77	2.38	1.12	1.96	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	90.49	5.87	4.02	4.86	2.01	1.68
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.57	1.90	0.95	0.95	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	54.80	2.94	1.71	0.98	1.47	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	34.25	4.86	2.43	1.10	1.55	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.34	1.46	1.17	0.88	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.66	1.17	1.36	0.78	1.75	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	52.10	3.44	0.53	1.85	1.59	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	0.74	3.72	0.74	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	1.80	2.16	0.72	0.36	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	19.87	1.99	1.42	0.85	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.69	1.18	0.39	0.79	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	35.55	2.54	1.27	0.76	1.02	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	25.16	2.00	0.80	0.80	2.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	29.68	2.93	0.84	0.42	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	24.29	0.46	1.38	0.92	2.29	0.92
Synoviocyte, donor1	11291-117A4	54.87	4.38	1.51	1.85	1.51	1.35
Synoviocyte, donor2	11368-117I9	59.00	6.37	2.68	3.02	2.85	1.34
Synoviocyte, donor3	11440-118H9	48.70	5.59	3.35	0.89	3.13	2.46
Trabecular Meshwork Cells, donor1	11532-120A2	43.95	3.57	1.07	0.36	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	9.91	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	31.95	2.78	0.93	1.16	0.93	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	28.75	3.87	1.00	0.43	0.65	1.36
Tracheal Epithelial Cells, donor2	11369-118A1	33.24	4.64	0.77	1.16	2.32	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	30.92	3.44	1.15	0.57	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	193.64	9.96	3.44	6.89	2.46	1.48
Urethra, donor2	10319-105A4	44.96	1.80	1.80	0.00	3.60	3.60
Urothelial Cells, donor1	11520-119H8	46.76	5.58	1.06	0.53	2.39	0.53
Urothelial Cells, donor2	11600-120H7	27.64	7.21	0.80	0.00	0.40	2.40
Urothelial Cells, donor3	11681-122H7	29.80	5.50	0.46	0.46	2.06	1.15
Urothelial cells, donor0	11216-116B1	50.15	5.35	2.67	1.11	1.11	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	34.70	0.00	0.89	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	32.88	0.00	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	1.37	1.37	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.58	2.07	1.38	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	30.21	0.58	1.74	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	34.36	2.08	1.04	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	0.92	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	15.52	2.74	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	28.62	1.97	1.36	1.60	1.23	0.25
Wilms' tumor cell line:HFWT	10597-108E3	32.56	4.40	0.00	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.71	7.54	0.28	0.00	0.56	1.68
achilles tendon, donor2	10292-104G4	24.80	0.00	4.13	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.41	1.02	0.25	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	44.35	3.71	0.46	0.70	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	44.63	5.94	0.59	0.36	0.95	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	30.20	3.81	1.09	0.00	0.54	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	15.74	0.56	0.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	29.40	2.96	0.63	0.42	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	89.89	3.53	2.20	2.20	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	63.30	2.45	0.82	0.82	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	44.27	2.33	0.78	0.39	0.78	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	34.59	5.89	0.74	0.55	1.84	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4.40	0.00	0.26	0.00	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.03	1.17	0.00	0.88	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	45.08	9.30	0.46	0.46	1.39	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.08	5.76	1.23	2.47	1.65	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.75	0.92	0.00	0.00	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.67	0.85	0.85	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	18.80	0.61	0.30	0.00	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	17.09	0.96	0.72	0.00	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.78	5.35	1.34	1.34	1.78	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.35	4.34	2.00	0.00	2.33	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	10.92	0.00	0.38	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	1.87	1.87	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	40.74	8.48	0.71	0.24	3.06	3.53
adipose tissue, adult, pool1	10010-101C1	95.09	7.60	2.17	3.41	4.65	2.02
adipose, donor1	10184-103D4	11.73	2.35	0.00	0.00	0.59	0.00
adipose, donor2	10185-103D5	28.39	4.87	1.62	0.81	1.62	0.81
adipose, donor3	10186-103D6	18.79	3.81	1.63	1.09	0.54	0.27
adipose, donor4	10187-103D7	30.34	4.33	0.87	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	22.25	3.47	0.63	0.00	1.58	1.42
adrenal gland, adult, pool1	10081-102A9	47.29	14.55	0.00	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	36.29	4.94	0.93	0.13	0.80	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.08	2.86	1.07	0.00	0.71	2.50
amniotic membrane cells, donor1	12235-129G3	66.31	9.27	2.55	0.23	2.78	2.09
amniotic membrane cells, donor2	12236-129G4	51.05	4.06	5.75	2.03	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	53.03	11.49	2.06	0.59	5.01	3.24
amygdala - adult, donor10196	10167-103B5	33.20	0.00	4.74	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	48.06	3.24	3.04	2.64	1.22	0.81
amygdala, newborn, donor10223	10360-105E9	14.20	0.65	1.29	0.97	1.29	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	65.83	4.07	1.27	1.02	0.89	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.09	2.43	1.32	0.66	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	14.36	1.67	0.33	0.33	1.00	1.34
aorta, adult, pool1	10052-101G7	43.93	2.94	0.98	0.78	1.77	2.35
appendix, adult	10189-103D9	39.98	1.55	1.55	0.39	1.16	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.64	5.16	2.41	0.69	0.69	0.69
artery, adult	10190-103E1	536.68	29.89	4.08	47.55	8.15	8.15
astrocytoma cell line:TM-31	10425-106D2	27.81	1.59	1.30	0.29	0.58	0.72
b cell line:RPMI1788	10427-106D4	62.31	4.76	0.74	0.45	1.04	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	92.67	6.38	2.22	3.88	1.66	3.33
bile duct carcinoma cell line:HuCCT1	10432-106D9	27.98	3.18	0.89	0.79	0.50	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	21.76	3.85	0.67	0.50	0.67	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	4.47	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	51.50	5.76	1.96	0.87	2.61	1.74
blood, adult, pool1	10053-101G8	19.93	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.97	3.43	1.71	0.86	0.00	0.00
bone marrow, adult	10192-103E3	47.24	4.05	1.35	0.67	2.70	0.67
brain, adult, donor1	10084-102B3	53.30	5.13	5.13	4.10	1.03	0.00
brain, adult, pool1	10012-101C3	43.43	2.00	2.90	2.23	0.89	0.45
brain, fetal, pool1	10085-102B4	16.03	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	7.60	1.65	0.33	0.00	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.21	3.62	0.87	0.12	1.12	1.25
breast, adult, donor1	10080-102A8	32.83	6.31	1.26	0.00	5.05	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	32.90	4.32	0.38	0.64	1.40	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.90	4.95	1.55	0.93	2.47	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	71.37	3.22	2.76	0.46	2.30	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	27.11	6.54	0.97	0.73	1.21	1.69
carcinoid cell line:NCI-H1770	10703-109H1	45.61	15.05	0.00	0.00	0.47	1.88
carcinoid cell line:NCI-H727	10735-110B6	11.38	1.75	0.66	0.00	0.44	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	17.11	5.39	0.32	0.00	1.90	2.22
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.87	5.59	1.06	0.27	1.60	1.06
caudate nucleus - adult, donor10196	10177-103C6	32.24	0.00	2.30	1.15	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	48.69	1.51	3.35	3.01	2.51	0.84
caudate nucleus, adult, donor10258	10379-105H1	59.60	1.53	0.76	2.29	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	30.76	1.46	3.30	1.10	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	29.13	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	51.88	1.28	4.27	3.20	0.43	1.07
cerebellum, adult, pool1	10083-102B2	27.94	1.03	4.83	3.45	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	23.25	0.00	2.49	4.15	1.66	0.83
cerebral meninges, adult	10188-103D8	38.83	1.26	2.27	1.26	1.76	0.50
cerebrospinal fluid, donor2	10294-104G6	267.50	8.77	3.65	21.93	8.04	4.39
cervical cancer cell line:D98-AH2	10552-107I3	52.48	10.64	0.72	0.86	2.16	0.72
cervical cancer cell line:ME-180	10553-107I4	17.23	1.49	0.33	0.33	0.00	0.00
cervix, adult, pool1	10013-101C4	33.70	5.14	1.89	0.52	2.94	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	102.83	1.53	2.79	4.18	0.56	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	5.23	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	83.51	16.28	1.12	1.37	3.73	3.73
choriocarcinoma cell line:SCH	10785-110H2	33.27	7.39	0.99	0.00	1.72	1.85
choriocarcinoma cell line:T3M-3	10618-108G6	25.85	9.49	0.71	0.71	3.79	3.08
chorionic membrane cells, donor1	12238-129G6	67.81	7.41	2.85	0.57	2.85	2.28
chorionic membrane cells, donor2	12239-129G7	42.85	3.58	1.19	1.49	0.89	1.49
chorionic membrane cells, donor3	12240-129G8	56.60	9.34	3.30	0.55	4.40	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	57.56	7.07	0.00	0.00	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.55	2.50	0.19	0.38	1.34	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1.69	0.21	0.21	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	5.73	0.78	0.52	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	56.00	4.11	4.34	1.37	1.14	1.60
clear cell carcinoma cell line:TEN	10636-108I6	39.04	3.64	0.87	0.35	0.52	0.69
colon carcinoma cell line:CACO-2	10513-107D9	22.88	1.46	0.18	0.92	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	46.75	9.12	1.52	0.00	1.52	1.52
colon, adult, donor1	10082-102B1	40.46	10.71	4.76	1.19	3.57	2.38
colon, adult, pool1	10014-101C5	81.31	13.63	1.41	1.18	4.58	2.94
colon, fetal, donor1	10070-101I7	55.00	16.07	0.00	1.24	3.09	4.33
common myeloid progenitor CMP, donor1	12130-128D6	68.75	0.00	9.17	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.47	1.27	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	17.96	1.36	0.60	0.45	0.30	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	20.16	1.41	0.71	0.56	0.14	0.56
corpus callosum, adult, pool1	10042-101F6	49.09	1.44	2.99	2.76	0.66	0.55
cruciate ligament, donor2	10295-104G7	33.23	2.43	0.81	1.62	2.43	1.62
diaphragm, fetal, donor1	10069-101I6	223.11	11.24	2.41	16.05	2.41	3.21
diencephalon, adult	10193-103E4	39.12	1.68	3.12	2.40	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	46.61	1.84	1.15	0.46	0.46	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	34.11	5.90	1.03	0.77	1.80	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	30.57	4.09	1.93	0.96	1.20	0.72
ductus deferens, adult	10196-103E7	33.39	2.49	1.99	0.50	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	2.88	2.88	1.44	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.76	3.68	4.41	1.47	2.94	2.94
dura mater, adult, donor1	10041-101F5	44.84	3.88	2.89	1.16	1.24	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	45.08	2.22	0.67	0.67	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	60.47	3.01	1.29	2.72	0.43	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	21.58	1.85	0.00	0.00	0.62	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	17.56	1.82	0.91	0.61	1.21	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.38	4.32	0.31	0.00	1.85	1.54
embryonic pancreas cell line:2C6	10603-108E9	22.33	0.00	0.00	0.00	0.00	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	32.18	2.35	0.00	1.01	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.65	0.91	1.45	1.09	1.09	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	45.19	3.38	1.45	0.48	1.13	1.13
epidermoid carcinoma cell line:A431	10426-106D3	22.23	6.45	0.78	0.11	1.00	1.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	63.79	12.43	0.22	0.99	1.10	2.31
epididymis, adult	10197-103E8	51.91	2.09	2.09	2.30	1.47	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.58	0.53	1.24	0.35	0.35	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.52	3.93	0.79	0.00	0.39	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	52.16	3.41	1.18	0.79	1.83	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	38.09	3.74	0.98	0.20	0.89	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	48.62	4.37	0.67	0.56	1.01	1.01
esophagus, adult, pool1	10015-101C6	41.62	6.58	2.12	1.27	1.81	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.80	4.88	4.13	0.88	1.38	0.75
eye - muscle inferior rectus, donor1	10272-104E2	96.58	4.83	2.41	9.66	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	265.13	6.31	4.21	23.15	2.10	0.00
eye - muscle medial, donor2	10299-104H2	133.94	13.39	2.98	22.32	2.98	4.46
eye - muscle superior, donor2	10297-104G9	119.24	1.15	0.00	11.46	4.59	3.44
eye - vitreous humor, donor1	10268-104D7	11.66	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	57.46	3.31	2.54	3.56	2.03	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	14.75	0.90	0.90	0.38	0.13	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.34	1.42	0.24	0.24	0.24	0.95
frontal lobe, adult, pool1	10040-101F4	46.26	2.25	5.35	2.16	0.94	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.93	2.10	1.50	1.50	0.90	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	91.62	5.76	2.19	3.11	2.29	2.29
gall bladder, adult	10198-103E9	53.84	8.21	2.17	0.72	0.72	1.45
gamma delta positive T cells, donor1	11937-126A2	56.91	2.68	0.00	0.54	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	52.29	1.12	0.37	0.00	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	48.37	2.11	1.27	1.27	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	67.89	9.28	1.16	0.58	1.93	1.35
gastric cancer cell line:AZ521	10549-107H9	39.68	1.15	0.82	0.33	1.31	0.98
gastric cancer cell line:GSS	10560-108A2	19.22	0.92	0.00	1.83	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.30	1.14	0.69	1.14	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	12.97	2.52	0.00	0.23	0.46	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	42.13	2.24	2.66	0.70	0.28	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.69	5.24	0.50	0.25	1.75	3.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.48	1.90	1.16	0.53	0.42	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	18.82	0.70	1.12	0.56	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	61.15	2.21	2.43	1.43	1.43	1.55
glioma cell line:GI-1	10413-106B8	25.19	3.22	1.46	0.88	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	43.73	2.92	3.64	2.19	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	52.24	2.44	1.95	2.44	1.46	0.49
globus pallidus, adult, donor10258	10367-105F7	52.03	1.37	5.48	2.74	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	38.90	1.07	0.53	2.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	0.00	0.00	0.00	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	149.44	13.12	2.88	5.76	4.48	2.88
hIPS +CCl2, biol_rep1	14383-156B9	41.78	6.43	0.46	1.38	0.92	1.38
hIPS +CCl2, biol_rep2	14384-156C1	49.84	4.12	0.46	2.29	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	50.24	1.29	0.64	1.29	1.93	1.29
hIPS, biol_rep1	14380-156B6	51.74	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	48.70	3.43	1.37	0.00	1.37	1.37
hIPS, biol_rep3	14382-156B8	60.69	1.10	1.10	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	20.69	0.57	0.29	0.00	1.15	0.86
heart - mitral valve, adult	10205-103F7	69.36	1.79	1.49	2.99	1.20	2.09
heart - pulmonic valve, adult	10206-103F8	146.95	7.58	1.83	9.15	1.31	2.35
heart - tricuspid valve, adult	10207-103F9	81.60	2.50	0.83	1.67	0.83	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	188.14	8.77	4.49	8.37	2.45	1.63
heart, adult, diseased, donor1	10051-101G6	298.08	11.07	4.68	12.35	2.55	1.28
heart, adult, pool1	10016-101C7	229.06	11.04	1.61	8.05	2.53	1.38
heart, fetal, pool1	10046-101G1	150.12	4.42	3.80	4.00	1.64	2.16
hepatic mesenchymal tumor cell line:LI90	10778-110G4	31.16	4.01	0.93	1.23	2.16	2.78
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	2.38	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	84.97	7.96	1.10	3.31	1.66	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	83.87	5.95	1.70	3.03	0.85	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	87.71	7.48	1.11	2.53	1.41	1.41
hepatoma cell line:Li-7	10484-107A7	27.14	1.00	0.33	1.22	0.78	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.76	2.51	0.10	0.00	0.50	0.60
hippocampus - adult, donor10196	10169-103B7	29.34	0.00	1.89	0.95	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	64.09	2.25	4.69	1.43	0.61	0.61
hippocampus, adult, donor10258	10374-105G5	38.84	1.49	1.00	0.00	1.49	0.50
hippocampus, newborn, donor10223	10363-105F3	25.03	0.70	1.06	1.06	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	87.28	10.38	2.44	12.21	2.44	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	88.16	13.55	1.77	4.32	1.96	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	82.01	9.39	1.52	4.32	2.54	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	13.53	1.13	0.00	0.00	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.88	3.10	1.55	0.52	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	25.05	3.04	0.38	1.52	1.14	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	28.32	2.34	1.17	2.34	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	31.67	3.23	1.72	0.86	1.08	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	21.69	0.83	0.42	0.83	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	28.65	2.13	1.89	2.37	1.18	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.30	2.89	1.45	0.80	0.16	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.09	0.00	1.35	0.67	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	39.12	6.73	0.63	1.41	1.10	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.34	7.86	0.98	0.00	1.47	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	40.15	4.36	0.00	2.62	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	17.75	2.86	0.57	0.19	1.34	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	15.70	3.05	0.00	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.49	2.00	0.50	1.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	39.37	6.41	3.20	1.13	0.94	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	36.38	4.55	0.91	0.45	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	43.54	4.39	1.57	1.25	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.56	3.43	2.12	0.98	1.14	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.26	2.03	2.61	0.87	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.92	2.39	1.20	2.39	1.49	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	63.74	7.21	1.11	3.33	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	58.20	6.85	1.71	1.43	0.86	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	81.66	5.72	1.22	4.90	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.86	1.06	0.00	0.35	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.52	0.00	0.00	1.27	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.95	2.42	1.21	0.61	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.65	6.72	0.52	0.52	2.59	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	34.54	4.65	0.66	1.33	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	41.81	3.33	1.80	1.03	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.92	1.79	1.28	1.02	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.20	2.27	2.27	0.00	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.80	1.68	2.02	1.68	1.01	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	57.24	7.25	1.21	3.38	1.21	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	76.21	6.68	1.34	1.34	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	60.98	7.32	0.49	1.95	1.95	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.50	1.53	1.22	0.31	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	0.00	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.19	2.65	0.33	0.66	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.24	6.02	1.64	3.28	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	42.34	3.62	0.00	1.09	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	39.50	2.14	0.71	1.07	1.07	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	2.39	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	27.90	2.71	1.90	1.08	0.27	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	17.24	2.16	1.08	1.35	1.35	1.08
immature langerhans cells, donor1	11904-125F5	27.12	1.94	1.45	0.48	0.73	1.21
immature langerhans cells, donor2	11905-125F6	26.14	2.38	0.79	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	53.09	1.89	5.68	2.56	1.42	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	1.30	0.00	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	68.29	2.60	2.10	2.00	0.70	0.50
kidney, fetal, pool1	10045-101F9	42.44	2.97	1.84	0.92	0.92	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	64.76	3.27	1.99	3.69	0.43	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.49	1.52	0.41	0.00	0.55	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	27.34	5.14	0.55	0.37	0.55	2.02
left atrium, adult, donor1	10079-102A7	87.18	1.63	2.72	4.90	3.81	2.18
left ventricle, adult, donor1	10078-102A6	129.95	7.58	3.03	5.56	3.54	5.06
leiomyoblastoma cell line:G-402	10721-110A1	16.14	2.46	1.64	1.09	0.82	1.37
leiomyoma cell line:10964C	10569-108B2	14.73	2.16	1.44	0.72	1.44	1.08
leiomyoma cell line:15242A	10570-108B3	30.43	2.72	1.63	1.09	1.63	1.09
leiomyoma cell line:15425	10571-108B4	19.43	0.97	2.91	0.73	1.46	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	19.05	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	38.69	4.18	0.00	2.09	5.23	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.47	0.00	0.24	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	37.65	3.59	2.81	0.62	2.50	1.72
liposarcoma cell line:SW 872	10726-110A6	30.46	1.95	0.73	0.49	0.24	1.10
liver, adult, pool1	10018-101C9	265.46	18.64	3.89	10.37	5.19	2.43
liver, fetal, pool1	10086-102B5	63.97	8.47	0.00	3.76	1.88	4.70
locus coeruleus - adult, donor10196	10182-103D2	41.12	1.90	2.33	2.62	0.73	0.58
locus coeruleus, adult, donor10252	10165-103B3	53.52	3.69	2.40	1.11	1.66	1.29
locus coeruleus, adult, donor10258	10375-105G6	37.52	2.26	1.41	3.10	1.41	0.85
locus coeruleus, newborn, donor10223	10362-105F2	24.82	0.42	2.94	2.52	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	26.30	1.11	0.97	0.00	0.69	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	36.54	3.45	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.58	4.75	1.32	0.79	1.32	0.79
lung, adult, pool1	10019-101D1	50.44	3.66	0.83	1.89	0.83	0.95
lung, fetal, donor1	10068-101I5	59.08	4.57	2.57	0.86	0.86	2.00
lung, right lower lobe, adult, donor1	10075-102A3	32.53	4.12	1.83	0.46	0.92	1.83
lymph node, adult, donor1	10077-102A5	15.15	0.95	0.00	0.47	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	23.23	3.07	1.32	0.00	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	30.34	1.51	0.45	0.30	0.45	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	37.38	0.00	0.00	0.85	2.55	0.85
mature adipocyte, donor1	12231-129F8	293.48	23.53	1.78	5.77	6.66	7.55
mature adipocyte, donor2	12232-129F9	268.54	21.38	3.32	6.02	9.75	6.23
mature adipocyte, donor3	12233-129G1	321.46	19.44	4.03	8.77	5.69	4.50
mature adipocyte, donor4	12234-129G2	281.12	20.27	4.21	8.42	7.63	3.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.12	4.29	3.57	0.48	2.14	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	0.00	4.51	1.13	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	50.39	2.57	3.13	0.74	1.29	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	27.32	1.59	3.49	1.91	0.95	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	18.77	0.43	2.99	1.28	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	36.79	1.69	3.21	1.52	1.52	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	47.54	2.55	1.70	1.27	0.85	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	23.33	0.00	1.79	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	37.64	4.54	3.24	1.95	0.65	1.95
medulla oblongata, adult, donor10252	10155-103A2	52.01	2.79	3.72	1.86	1.24	0.62
medulla oblongata, adult, pool1	10038-101F2	76.40	3.59	4.16	9.22	1.06	1.06
medulla oblongata, newborn, donor10223	10361-105F1	27.77	1.04	0.35	2.43	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	19.26	2.21	0.66	0.66	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	19.20	0.98	0.37	0.61	0.49	0.61
melanoma cell line:COLO 679	10514-107E1	35.79	1.01	2.44	1.29	0.57	0.43
melanoma cell line:G-361	10465-106H6	37.73	2.44	1.90	2.17	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	25.15	2.89	1.81	0.36	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	57.28	3.52	0.00	0.00	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	11.67	1.81	0.00	0.78	0.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	54.93	5.52	4.14	0.46	2.92	2.76
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.54	4.91	2.36	1.09	1.64	1.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	48.04	3.31	3.73	0.83	2.90	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	40.04	5.90	2.95	0.84	2.95	3.37
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	47.95	6.16	2.70	1.73	2.50	2.31
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	51.36	7.63	5.55	2.08	2.78	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.60	2.57	2.23	1.72	0.51	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	31.97	3.68	1.84	0.92	2.42	1.96
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.26	2.25	2.12	0.93	1.33	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	30.11	2.84	0.95	0.68	1.49	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	52.92	3.84	2.70	1.56	1.14	1.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	56.32	1.32	1.65	2.31	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	78.73	6.09	4.01	3.04	1.94	2.35
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	55.50	4.89	1.75	1.05	3.14	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	49.61	6.74	3.27	1.02	1.63	2.45
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	35.95	3.59	1.08	1.80	0.72	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	61.24	7.86	4.45	1.86	3.31	1.55
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	57.68	8.89	2.51	4.33	1.60	2.96
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	67.97	4.20	1.68	2.10	1.68	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	64.26	3.29	2.24	2.24	2.24	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	62.76	7.35	3.24	2.45	2.89	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	73.26	5.52	3.68	0.74	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.38	5.44	2.86	2.58	1.14	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	73.26	0.42	1.68	7.16	0.84	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	41.10	4.11	3.20	4.57	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	39.90	1.28	1.79	1.79	1.53	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	48.42	1.05	2.88	1.57	1.83	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	43.75	3.08	3.39	0.31	0.92	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	47.78	3.53	4.00	0.24	1.41	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	45.35	3.05	3.72	1.02	2.03	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.91	3.93	1.57	1.18	1.57	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.34	2.78	1.85	0.93	1.39	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	53.93	4.04	3.46	1.73	2.60	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	45.07	1.78	1.34	2.01	1.56	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.19	3.12	2.88	1.44	2.64	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.13	4.40	2.20	1.47	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	45.31	3.02	1.01	2.35	0.34	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	50.76	2.87	4.09	0.82	1.23	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	48.97	5.15	4.73	3.01	0.86	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	5.47	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	10.33	10.33	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	58.46	3.90	3.57	1.30	1.62	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	52.38	2.91	5.82	1.45	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	57.04	3.73	2.13	3.73	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	46.61	1.64	4.91	1.64	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	44.31	2.72	4.66	1.94	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	6.30	2.10	2.10	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	45.70	2.98	4.97	0.99	1.99	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	38.54	2.37	1.19	0.59	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	58.49	1.22	0.00	8.53	3.66	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	47.50	6.97	0.00	0.63	1.90	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	53.12	2.41	2.41	0.69	1.72	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	4.30	2.15	0.00	2.15	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	3.44	0.00	6.89	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	34.23	1.22	4.07	1.22	2.44	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	33.37	2.38	3.97	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	2.36	0.59	0.59	1.18	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.94	1.56	2.18	0.62	1.87	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	4.01	4.01	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	62.68	3.55	1.18	3.55	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	71.90	2.57	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	77.79	3.44	2.75	2.75	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	345.38	13.85	2.97	16.33	2.97	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	263.55	17.94	3.36	23.55	2.24	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	334.57	9.54	4.45	24.17	1.91	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	511.79	15.31	4.84	34.66	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	527.70	10.90	10.90	43.61	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	523.30	24.07	13.94	26.61	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	402.97	24.28	4.86	16.99	5.46	3.64
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	379.59	13.56	9.04	18.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	319.59	13.18	5.77	13.18	4.12	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	106.36	4.56	2.38	4.96	1.59	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	110.98	7.79	2.27	6.49	2.27	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	128.35	6.11	2.04	5.09	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	0.00	0.77	0.00	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	53.39	4.49	0.94	0.94	0.94	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.91	2.32	1.85	0.23	0.23	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	3.29	0.00	0.51	0.00	0.00	0.21
mesothelioma cell line:Mero-25	10850-111F4	8.85	0.45	0.68	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	202.18	17.36	2.69	5.62	2.44	3.67
mesothelioma cell line:Mero-48a	10852-111F6	65.76	5.09	3.54	1.33	1.77	1.33
mesothelioma cell line:Mero-82	10853-111F7	17.61	0.79	1.31	0.53	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	20.43	1.53	0.85	0.17	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	54.85	4.04	1.26	2.02	0.51	1.26
mesothelioma cell line:Mero-95	10856-111G1	41.41	3.11	4.55	1.24	1.04	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	32.30	1.16	0.83	0.99	0.50	1.33
mesothelioma cell line:NCI-H226	10846-111E9	24.25	1.09	1.45	1.09	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	39.12	4.10	2.05	1.71	1.20	1.20
mesothelioma cell line:NCI-H28	10845-111E8	46.06	4.83	0.76	1.27	1.02	0.25
mesothelioma cell line:No36	10857-111G2	23.16	1.30	1.30	1.63	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	37.66	3.52	1.63	1.08	2.17	0.81
migratory langerhans cells, donor1	11901-125F2	66.02	1.34	2.30	0.38	0.19	1.15
migratory langerhans cells, donor2	11902-125F3	58.62	1.95	0.85	0.73	0.12	0.61
migratory langerhans cells, donor3	11903-125F4	63.72	1.79	1.08	0.72	0.54	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.26	3.92	0.33	1.31	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	61.89	3.60	0.85	2.33	1.70	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	24.65	6.45	1.15	0.46	2.30	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.28	0.38	0.00	0.00	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	42.13	4.44	1.48	1.11	0.37	0.92
myeloma cell line:PCM6	10474-106I6	20.76	1.38	0.59	0.40	0.40	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	2.03	0.00	1.01	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.52	6.08	0.78	0.39	2.94	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.16	3.45	2.12	0.33	1.00	1.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.31	4.41	1.99	0.15	1.25	1.40
nasal epithelial cells, donor2	12227-129F4	23.18	2.76	2.21	1.10	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	18.40	3.91	0.23	0.23	1.15	0.69
neuroblastoma cell line:NB-1	10539-107G8	30.68	1.31	0.37	1.31	0.75	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	62.63	13.08	2.11	1.05	7.59	6.33
neuroblastoma cell line:NH-12	10555-107I6	30.75	2.61	0.56	0.19	0.75	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.71	3.08	1.19	0.00	2.85	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	44.03	6.65	2.06	1.58	3.96	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	13.89	1.61	0.60	0.00	0.60	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	64.94	5.06	1.06	3.46	2.93	1.06
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	39.84	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	28.41	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	111.96	3.38	0.85	1.69	1.18	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	41.63	7.20	0.00	0.80	2.40	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.93	2.24	1.60	1.28	0.64	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	31.27	2.10	2.36	1.31	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	51.09	1.59	3.75	3.84	1.12	0.84
occipital cortex - adult, donor10196	10172-103C1	35.03	0.00	6.18	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	67.09	3.22	2.95	4.03	1.61	1.61
occipital cortex, newborn, donor10223	10355-105E4	26.20	0.36	2.55	0.73	0.73	1.09
occipital lobe, adult, donor1	10076-102A4	36.74	2.10	4.20	2.36	1.84	0.79
occipital lobe, fetal, donor1	10073-102A1	15.45	2.57	3.00	0.86	1.72	0.86
occipital pole, adult, pool1	10036-101E9	47.07	2.13	4.34	2.21	0.79	0.71
olfactory region, adult	10195-103E6	41.08	1.34	3.06	2.87	1.15	0.76
optic nerve, donor1	10277-104E7	22.01	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	24.60	6.04	1.25	0.11	0.80	2.05
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	29.81	4.67	0.41	0.14	0.55	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.45	8.30	1.52	0.85	2.20	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.65	5.66	0.92	0.35	0.69	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	65.55	3.82	3.82	2.06	2.35	3.53
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	1.87	0.00	0.00	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	1.70	0.00	0.00	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	36.77	14.24	1.92	1.22	4.45	2.71
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.68	7.33	0.73	0.55	1.28	2.75
pancreas, adult, donor1	10049-101G4	88.42	5.64	2.82	0.94	2.82	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	27.95	9.22	0.28	1.12	3.07	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	32.37	1.53	0.17	1.36	0.17	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	17.55	2.48	0.99	0.33	0.99	0.83
paracentral gyrus, adult, pool1	10035-101E8	48.69	0.92	4.94	3.02	0.73	0.73
parietal cortex, adult, donor10258	10373-105G4	33.76	1.47	2.94	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	32.92	1.88	3.76	0.94	2.82	2.82
parietal lobe, adult, donor10252	10157-103A4	53.30	1.43	2.00	1.71	1.43	0.86
parietal lobe, adult, pool1	10034-101E7	51.20	1.76	4.23	3.00	1.23	0.79
parietal lobe, fetal, donor1	10072-101I9	19.40	1.94	3.88	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	23.93	1.12	2.24	2.24	1.12	0.00
parotid gland, adult	10199-103F1	37.62	1.23	0.00	0.62	1.23	0.00
penis, adult	10200-103F2	200.88	13.43	4.30	27.39	2.69	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	39.42	8.37	3.53	0.19	5.39	2.05
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	26.37	1.60	1.31	0.44	0.29	0.87
pineal gland - adult, donor10196	10179-103C8	25.16	1.29	0.00	0.65	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	26.65	1.18	3.55	0.59	2.37	3.55
pineal gland, adult, donor10258	10377-105G8	21.95	2.51	1.25	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	65.77	5.06	8.09	4.05	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	70.88	6.25	10.42	1.56	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	65.55	2.55	7.66	2.55	3.40	0.85
placenta, adult, pool1	10021-101D3	65.36	4.73	3.87	0.97	1.72	1.61
plasma cell leukemia cell line:ARH-77	10840-111E3	31.65	4.90	0.53	0.40	1.19	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	55.87	6.54	2.02	1.09	2.49	1.56
pons, adult, pool1	10033-101E6	39.07	0.95	4.48	2.84	1.03	0.69
postcentral gyrus, adult, pool1	10032-101E5	49.69	1.05	6.36	2.70	0.70	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	94.11	14.64	0.00	4.18	6.27	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	5.51	0.00	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	30.88	1.75	1.31	1.02	1.46	1.31
prostate cancer cell line:PC-3	10439-106E7	68.79	9.08	2.00	1.45	1.63	0.91
prostate, adult, pool1	10022-101D4	43.26	4.90	2.09	0.73	2.99	1.72
putamen, adult, donor10196	10176-103C5	46.74	2.12	5.90	1.42	1.42	1.18
putamen, adult, donor10252	10152-102I8	49.02	1.96	0.00	0.00	3.92	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	0.00	1.09	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	44.70	1.69	2.90	1.21	0.97	0.24
putamen, newborn, donor10223	10365-105F5	19.49	2.25	3.00	1.50	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	0.00	0.00	0.00	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	43.12	12.52	4.17	0.00	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.82	4.45	4.66	0.42	0.85	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	100.24	9.11	1.24	0.41	1.66	2.90
retina, adult, pool1	10030-101E3	43.04	3.08	3.98	0.89	1.79	1.19
retinoblastoma cell line:Y79	10475-106I7	30.14	5.46	1.04	0.78	1.04	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.64	2.21	3.32	0.61	0.61	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	17.15	3.37	0.00	0.84	1.12	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	24.25	5.30	0.76	0.00	0.00	1.52
salivary acinar cells, donor1	11771-123I7	33.67	3.40	2.43	0.81	0.49	1.13
salivary acinar cells, donor2	11772-123I8	25.61	3.30	2.75	0.41	0.55	1.10
salivary acinar cells, donor3	11773-123I9	15.23	3.97	1.99	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	38.32	5.72	5.72	0.00	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.98	1.85	1.43	0.51	1.01	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.04	2.35	1.65	0.94	0.71	1.06
seminal vesicle, adult	10201-103F3	51.85	7.41	5.29	0.53	1.06	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	88.91	5.83	2.92	3.40	1.46	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	112.73	5.03	1.01	1.26	1.01	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	112.40	5.02	2.01	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	29.28	1.48	0.27	0.13	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	9.95	1.22	0.22	0.33	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	16.64	3.61	0.13	0.39	1.03	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	701.53	21.99	9.22	46.11	11.35	5.67
skeletal muscle, adult, pool1	10023-101D5	640.70	29.26	4.80	50.01	6.72	5.76
skeletal muscle, fetal, donor1	10066-101I3	86.43	7.04	1.01	9.05	2.01	1.01
skin, adult, donor1	10074-102A2	13.57	6.79	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	61.23	5.05	4.42	5.05	3.79	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	16.34	1.00	0.67	0.33	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.89	3.47	2.21	4.73	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	45.30	3.66	2.12	0.77	2.51	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	6.26	0.82	0.00	0.00	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	42.14	6.59	0.64	0.00	1.93	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	85.64	3.92	0.87	2.18	1.74	2.40
small intestine, adult, pool1	10024-101D6	74.17	16.48	3.11	2.03	6.69	5.61
small intestine, fetal, donor1	10064-101I1	27.03	10.81	1.72	0.49	4.18	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	22.05	2.05	0.51	1.03	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	42.39	5.17	2.33	0.78	1.81	1.81
somatostatinoma cell line:QGP-1	10781-110G7	12.87	9.92	0.27	0.00	3.48	2.68
spinal cord - adult, donor10196	10181-103D1	28.68	2.06	3.90	1.38	0.69	0.46
spinal cord, adult, donor10252	10159-103A6	57.17	2.76	0.00	0.39	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	24.21	0.00	6.23	2.08	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	45.74	1.83	1.22	1.22	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	23.88	0.92	0.46	0.92	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	40.18	4.93	0.75	1.05	2.39	2.84
spleen, adult, pool1	10025-101D7	20.93	0.77	0.11	0.00	1.21	0.44
spleen, fetal, pool1	10044-101F8	27.25	1.43	1.11	0.32	0.40	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.14	0.10	0.31	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.23	2.85	0.38	0.00	1.52	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	141.53	5.59	4.19	3.84	1.40	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.28	4.69	0.78	0.00	1.17	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.95	6.08	0.79	0.90	1.01	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	1.69	0.00	0.42	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	52.04	3.38	0.00	1.69	1.27	0.42
stomach, fetal, donor1	10062-101H8	34.18	13.88	4.27	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	54.69	4.56	1.71	1.71	0.57	3.42
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	39.67	0.83	2.08	1.04	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	54.83	0.00	2.59	1.55	2.59	0.52
substantia nigra, newborn, donor10223	10358-105E7	31.09	2.12	2.12	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	14.44	0.92	1.15	0.23	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	51.79	2.12	5.09	2.97	0.42	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	10.68	2.14	3.56	0.71	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.02	1.32	1.32	2.20	0.88	0.44
tenocyte, donor1	11763-123H8	59.35	4.19	5.93	2.44	4.89	3.49
tenocyte, donor2	11765-123I1	49.21	4.20	3.05	1.91	5.34	0.76
tenocyte, donor3	11768-123I4	76.36	3.34	4.82	3.34	1.85	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	70.53	7.99	1.19	1.19	0.85	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	31.29	2.47	0.31	0.62	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	35.49	3.10	0.77	0.46	0.62	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	117.55	11.30	1.90	3.30	1.14	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	142.57	12.86	0.76	3.03	1.51	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	127.60	20.18	0.55	1.42	1.85	2.51
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	141.03	18.24	2.61	5.86	1.30	3.26
testis, adult, pool1	10026-101D8	33.18	2.15	1.29	1.61	1.93	1.18
testis, adult, pool2	10096-102C6	33.38	1.80	3.16	0.00	0.90	1.35
thalamus - adult, donor10196	10168-103B6	27.60	0.00	0.00	2.21	2.21	0.00
thalamus, adult, donor10252	10154-103A1	52.35	1.72	0.63	1.09	0.94	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	63.12	0.00	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.30	1.98	1.65	2.64	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	20.14	0.58	1.73	1.15	0.00	0.00
throat, adult	10209-103G2	217.96	7.24	3.99	24.22	4.24	2.25
throat, fetal, donor1	10061-101H7	43.88	3.96	3.35	4.88	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	10.33	1.19	0.20	0.00	0.99	1.39
thymus, adult, pool1	10027-101D9	23.86	1.19	0.40	0.40	0.50	0.60
thymus, fetal, pool1	10043-101F7	30.34	2.39	0.42	0.31	0.52	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.59	6.12	1.33	1.06	1.60	1.60
thyroid carcinoma cell line:TCO-1	10783-110G9	45.68	4.05	1.82	1.54	0.70	0.84
thyroid, adult, pool1	10028-101E1	47.22	1.96	1.96	1.31	0.28	0.28
thyroid, fetal, donor1	10060-101H6	42.45	3.43	4.22	2.90	1.58	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	6.16	0.00	6.16	3.08	6.16
tongue, adult	10203-103F5	229.09	9.30	3.26	20.47	2.79	1.86
tongue, fetal, donor1	10059-101H5	161.58	5.52	4.73	24.43	1.18	2.36
tonsil, adult, pool1	10047-101G2	46.98	4.71	1.60	2.10	1.70	1.30
trachea, adult, pool1	10029-101E2	42.37	3.84	1.64	0.90	1.47	1.64
trachea, fetal, donor1	10058-101H4	72.71	5.39	4.62	6.16	1.54	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	3.90	1.42	0.00	1.42	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	27.86	4.66	0.30	0.41	1.11	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	70.51	5.95	3.60	2.04	1.88	2.04
tridermal teratoma cell line:HGRT	10694-109G1	20.93	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	52.74	4.32	0.34	1.19	0.76	0.34
umbilical cord, fetal, donor1	10057-101H3	75.11	2.09	4.17	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	27.98	4.27	1.71	0.51	2.22	2.22
uterus, fetal, donor1	10055-101H1	52.73	8.70	1.54	0.51	4.61	2.56
vagina, adult	10204-103F6	23.91	5.17	0.00	0.00	0.65	1.29
vein, adult	10191-103E2	60.94	7.01	1.10	2.41	1.75	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	32.85	2.67	1.07	0.00	0.53	0.53